Status:

RECRUITING

Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections

Lead Sponsor:

Istituto Ortopedico Rizzoli

Conditions:

Hip Infection

Eligibility:

All Genders

18+ years

Brief Summary

The aim of the present clinical study, of prospective observational nature with biological study, is to conduct a clinical investigation on the the efficacy of a device coated with bacteriostatic silv...

Detailed Description

Among the various complications that can arise in orthopaedics following implant surgery, peri-prosthetic joint infections (Periprosthetic Joint Infection -PJI) represent one of the most feared compli...

Eligibility Criteria

Inclusion

  • Patients aged ≥ 18 years;
  • Immunocompromised patients and/or diabetic patients.
  • Patients who have given consent

Exclusion

  • Patients aged \< 18 years;
  • Pregnant women;

Key Trial Info

Start Date :

March 12 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 1 2029

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT06887816

Start Date

March 12 2025

End Date

March 1 2029

Last Update

March 20 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Istituto Ortopedico Rizzoli

Bologna, BO, Italy, 40136

2

Ospedale Mazzolani Vandini

Argenta, Italia, Italy, 44011